SAIPARENT521.00

Sai Parenterals Limited

· Pharma & Health
₹ CrorePeersINDOCOPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,302 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Non-current Assets
+ Property, Plant & Equipment61.6
+ Capital Work-in-Progress212.2
+ Goodwill124.6
+ Other Intangibles47.9
+ Other Non-current Financial Assets131.7
Non-current Financial Assets131.7
+ Deferred Tax Assets8.1
+ Other Non-current Assets16.1
Total Non-current Assets602.2
Current Assets
+ Inventories171.8
+ Trade Receivables181.0
+ Cash & Cash Equivalents417.0
+ Short-term Loans2.6
+ Other Current Financial Assets17.1
Current Financial Assets617.7
+ Other Current Assets32.5
Total Current Assets822.0
Total Assets1,424.2
Equity
+ Equity Share Capital22.1
+ Other Equity / Reserves468.7
Equity — Owners of Parent490.8
+ Minority Interest4.4
Total Equity495.1
Liabilities
+ Borrowings — Non-current90.4
+ Other Non-current Financial Liab135.5
Non-current Financial Liabilities225.9
+ Provisions — Non-current0.8
+ Other Non-current Liabilities129.8
Non-current Liabilities356.5
+ Borrowings — Current229.1
+ Trade Payables148.6
+ Other Current Financial Liab131.8
Current Financial Liabilities509.5
+ Provisions — Current15.8
+ Other Current Liabilities47.3
Current Liabilities572.6
Total Liabilities929.1
Total Equity & Liabilities1,424.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current24.5
+ Dues to Other Creditors — Current124.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.